Latest News
Ascentage Pharma receives China IND clearance for BTK degrader APG‑3288
...
BioArctic reports higher royalties as Leqembi sales reach JPY20.7bn in Q4 2025
6 February 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) reported on Friday that its Japanese partner Eisai Co Ltd (TYO:4523) generated preliminary global Leqembi (lecanemab) sales of JPY20.7bn in the fourth quarter of 202...
K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001
6 February 2026 - Clinical-stage biotechnology company K36 Therapeutics Inc on Thursday announced completion of dosing in the first patient cohort of its Phase 1 clinical trial evaluating KTX-2001, a first-in-class, orally administered, selective NSD...
Partner Therapeutics' zenocutuzumab-zbco granted US FDA Orphan Drug Designation for treatment of cholangiocarcinoma
6 February 2026 - Biotechnology company Partner Therapeutics Inc (PTx) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to zenocutuzumab-zbco for the treatment of adults with advanced unre...
FDA issues EUA for Boehringer Ingelheim's IVOMEC (ivermectin) 1% Injection
6 February 2026 - German biopharmaceutical company Boehringer Ingelheim announced on Thursday that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the use of IVOMEC (ivermectin) 1% Injection for the preve...